Filing Details

Accession Number:
0000899243-19-019144
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-03 16:14:17
Reporting Period:
2019-07-01
Accepted Time:
2019-07-03 16:14:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1743881 Bridgebio Pharma Inc. BBIO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1779990 Thomas Michael Henderson C/o Bridgebio Pharma, Inc.
421 Kipling Street
Palo Alto CA 94301
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-01 8,420 $0.00 8,420 No 4 M Direct
Common Stock Acquisiton 2019-07-01 8,420 $0.00 16,840 No 4 M Direct
Common Stock Acquisiton 2019-07-01 151,563 $0.00 168,403 No 4 M Direct
Common Stock Acquisiton 2019-07-01 5,364 $0.00 173,767 No 4 M Direct
Common Stock Acquisiton 2019-07-01 7,000 $17.00 180,767 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Management Incentive Units Disposition 2019-07-01 8,420 $0.00 8,420 $0.00
Common Stock Management Incentive Units Disposition 2019-07-01 8,420 $0.00 8,420 $0.00
Common Stock Management Incentive Units Disposition 2019-07-01 151,563 $0.00 151,563 $0.00
Common Stock Management Incentive Units Disposition 2019-07-01 5,364 $0.00 5,364 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
0 No 4 M Direct
0 No 4 M Direct
0 No 4 M Direct
Footnotes
  1. Immediately prior to the closing of the Issuer's initial public offering (the "IPO"), all units in BridgeBio Pharma LLC (the "LLC") held by the Reporting Person were exchanged for shares of Common Stock, par value $0.001 per share (the "Common Stock"), of the Issuer in an exempt transaction pursuant to Rules 16b-3, 16b-6 and 16b-7 (the "Reorganization"). In connection with the Reorganization, a wholly-owned subsidiary of the Issuer was merged with and into the LLC, and shares of Common Stock were allocated to the holders of outstanding units in the LLC pursuant to the distribution provisions of the Fourth Amended and Restated Limited Liability Company Agreement of the LLC, dated November 20, 2018, as amended, based upon the liquidation value of the LLC, assuming it was liquidated immediately prior to the closing of the IPO with a value implied by the IPO price of $17.00 per share. The LLC units have no expiration date.
  2. Represents shares of restricted Common Stock issuable in the Reorganization in exchange for Management Incentive Units in the LLC held by the Reporting Person. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of March 22, 2016, such that the shares shall be fully vested on March 22, 2021, subject to the Reporting Person's continued service relationship to the Issuer through each vesting date.
  3. Represents shares of restricted Common Stock issuable in the Reorganization in exchange for Management Incentive Units in the LLC held by the Reporting Person. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of January 1, 2017, such that the shares shall be fully vested on January 1, 2022, subject to the Reporting Person's continued service relationship to the Issuer through each vesting date.
  4. Represents shares of restricted Common Stock issuable in the Reorganization in exchange for Management Incentive Units in the LLC held by the Reporting Person. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of October 31, 2018, such that the shares shall be fully vested on October 31, 2023, subject to the Reporting Person's continued service relationship to the Issuer through each vesting date.
  5. Represents shares of restricted Common Stock issuable in the Reorganization in exchange for Management Incentive Units in the LLC held by the Reporting Person. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of February 12, 2019, such that the shares shall be fully vested on February 12, 2024, subject to the Reporting Person's continued service relationship to the Issuer through each vesting date.